Unibest
← Back to patent-cliff list

CAS 114772-54-2

4'-(bromomethyl)-[1,1'-biphenyl]-2-carbonitrile

Codes: TELM-029, OLME-011, IRBE-004, ALIS-008, VALS-001, AZILS-017, AZIL-004, CAND-004

Application context (from source-drug indications)

HypertensionTelmisartan/Amlodipine Besylate/HydrochlorothiazideHypertensionRosuvastatin Calcium/TelmisartanHyperlipidaemiaRosuvastatin Calcium/TelmisartanHypertensionOlmesartan Medoxomil/Amlodipine MaleateHypertensionOlmesartan Medoxomil/Amlodipine orotateHypertensionAtorvastatin Calcium Hydrate/IrbesartanHyperlipidaemiaAtorvastatin Calcium Hydrate/IrbesartanHypertensionAllisartan IsoproxilHypertensionLevamlodipine Besylate/ValsartanEssential hypertensionLevamlodipine Besylate/ValsartanEssential hypertensionValsartan/Amlodipine OrotateEssential hypertensionValsartan/Lercanidipine HydrochlorideHypertensionIrbesartan/TrichlormethiazideHypertensionAzilsartanEssential hypertensionAzilsartanType 2 diabetesAzilsartanObesityAzilsartanDiabetesAzilsartanHypertensionAzilsartan Medoxomil Potassium/ChlorthalidoneEssential hypertensionAzilsartan Medoxomil Potassium/ChlorthalidoneHypertensionAmlodipine Besylate/Candesartan CilexetilHypertensionOlmesartan Medoxomil/AzelnidipineHypertensionAmlodipine Besylate/TelmisartanEssential hypertensionAmlodipine Besylate/Olmesartan MedoxomilHypertensionAmlodipine Besylate/Olmesartan MedoxomilHypertensionOlmesartan MedoxomilIschaemic strokeOlmesartan MedoxomilHeart failureOlmesartan MedoxomilMetabolic syndromeOlmesartan MedoxomilGlomerulonephritisOlmesartan MedoxomilType 2 diabetesOlmesartan MedoxomilHypertensionTelmisartanBreast cancerTelmisartanCardiomyopathyTelmisartanAlzheimer's diseaseTelmisartanRisk-reduction measureTelmisartanMyocardial infarctionTelmisartanLeft ventricular dysfunctionValsartanHypertensionValsartanEssential hypertensionValsartanPulmonary arterial hypertensionValsartanRight ventricular dysfunctionValsartanPost-myocardial infarction syndromeValsartanOesophageal diseaseIrbesartanHypertensionIrbesartanDiabetic nephropathyIrbesartanHypercholesterolaemiaIrbesartanAlbuminuriaIrbesartanType 2 diabetesIrbesartanEssential hypertensionAzilsartan Medoxomil PotassiumHypertensionAzilsartan Medoxomil PotassiumHypertensionCandesartan CilexetilHeart failureCandesartan CilexetilEssential hypertensionCandesartan CilexetilMigraineCandesartan CilexetilCOVID-19Candesartan CilexetilManiaCandesartan Cilexetil

Source drugs (routes using this intermediate)

DrugTierExpiry
Telmisartan/Amlodipine Besylate/HydrochlorothiazideTier C — Watch / trade-
Rosuvastatin Calcium/TelmisartanTier C — Watch / trade-
Olmesartan Medoxomil/Amlodipine MaleateTier C — Watch / trade-
Olmesartan Medoxomil/Amlodipine orotateTier C — Watch / trade-
Atorvastatin Calcium Hydrate/IrbesartanTier C — Watch / trade-
Allisartan IsoproxilTier C — Watch / trade-
Levamlodipine Besylate/ValsartanTier C — Watch / trade-
Valsartan/Amlodipine OrotateTier C — Watch / trade-
Valsartan/Lercanidipine HydrochlorideTier C — Watch / trade-
Irbesartan/TrichlormethiazideTier C — Watch / trade-
AzilsartanTier C — Watch / trade-
Azilsartan Medoxomil Potassium/ChlorthalidoneTier C — Watch / trade-
Amlodipine Besylate/Candesartan CilexetilTier C — Watch / trade-
Olmesartan Medoxomil/AzelnidipineTier C — Watch / trade-
Amlodipine Besylate/TelmisartanTier C — Watch / trade-
Amlodipine Besylate/Olmesartan MedoxomilTier C — Watch / trade-
Olmesartan MedoxomilTier B — Position early-
TelmisartanTier B — Position early-
ValsartanTier B — Position early-
IrbesartanTier B — Position early-
Azilsartan Medoxomil PotassiumTier C — Watch / trade-
Candesartan CilexetilTier B — Position early-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Allisartan IsoproxilOptimised routesteps: 4total yield: 1.78 g
2-butyl-4-chloro-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazole-5-carbaldehyde→4'-(bromomethyl)-[1,1'-biphenyl]-2-carbonitrile→2-butyl-4-chloro-1H-imidazole-5-carbaldehyde→4'-((2-butyl-4-chloro-5-formyl-1H-imidazol-1-yl)methyl)-[1,1'-biphenyl]-2-carbonitrile→2-butyl-4-chloro-1-((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazole-5-carboxylic acid→((isopropoxycarbonyl)oxy)methyl 2-butyl-4-chloro-1-((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazole-5-carboxylate

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.